Tag: Q4 2016

July 15, 2018

5 Top Weekly NASDAQ Biotech Stocks: Arbutus on Top

Adamis Pharmaceutical, Juniper Pharmaceuticals, Anavex Life Sciences, Arbutus BioPharma and Soleno Therapeutics were last week's top gainers on the NASDAQ...
July 12, 2018

Silver Price Update: Q2 2018 in Review

What happened to silver in Q2 2018? Our silver price update outlines key market developments and explores what could happen...
July 5, 2018

Best Copper Stocks of 2018 on the TSX

What are the best copper stocks on the TSX so far this year? These five companies have seen the biggest...
July 1, 2018

5 Top Weekly NASDAQ Biotech Stocks: Avid Bioservices on Top

Avid Bioservices, Arbutus Biopharma, Catalyst, ArQule and CTI BioPharma were last week's top gainers on the NASDAQ Biotechnology Index.
June 10, 2018

5 Top Weekly NASDAQ Biotech Stocks: MEI Pharma on Top

MEI Pharma, Anavex Life Sciences, Trillium Therapeutics, Celldex Therapeutics and Ophthotech were last week's top gainers on the NASDAQ Biotechnology...
May 16, 2018

10 Top Cybersecurity Companies

The cybersecurity industry is quickly expanding in response to the need for increased computer security. Here are the 10 top...
May 13, 2018

5 Top Weekly NASDAQ Biotech Stocks: Helius Up 43.19 Percent

Helius Medical Technologies, vTv Therapeutics, Second Sight Medical Products, Depomed and Senomyx were last week's top gainers on the NASDAQ.
May 2, 2018

Santacruz Silver Reports Fourth Quarter Results

Santacruz Silver Mining Ltd. reports on its financial and operating results for the fourth quarter of 2017.
April 30, 2018

Pasinex Reports Net Income of $5.8 Million for 2017, Strong Operating Results at Pinargozu and Operating Guidance for 2018

Pasinex Resources Limited (CSE:PSE,FSE:PNX) (The “Company” or “Pasinex”) today reported net income for 2017 of $5.8 million; a 700 percent...
April 29, 2018

5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent

Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.